Offering four key software-as-a-service features, the cloud-based enterprise imaging suite reportedly offers enhanced security and storage and facilitates streamlined radiology workflows.
Providing a new suite of cloud-based features to foster workflow efficiencies in radiology, GE HealthCare unveiled the new Genesis enterprise imaging portfolio at the Healthcare Information and Management Systems Society (HIMSS) 2025 conference.
Facilitating easier access, management and storage of images, GE HealthCare said the Genesis suite is comprised of four key software-as-a-solution (SAAS) features.
Key benefits of the new Genesis enterprise imaging portfolio include enhanced vendor-neutral image archiving, AI-powered data migration and cloud-based storage management, according to GE HealthCare. (Image courtesy of Adobe Stock.)
The suite includes the Edge feature, which enables hybrid solutions that allow facilities to combine existing investments in imaging hardware and software with cloud-based privacy and security safeguards. Other benefits include enhanced vendor-neutral image archiving, AI-powered data migration and cloud-based storage management, according to GE HealthCare.
“With the launch of the Genesis portfolio, we will be providing cloud-enabled solutions that can help transform patient care through accessible, sharable, and secure imaging data while simultaneously improving clinical and operational efficiencies,” noted Scott Miller, the CEO of Enterprise Imaging Solutions at GE HealthCare.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.